Treatment of functional gastrointestinal disorders in infants
O.L. Krivusha, V.L. Babich, N.Y. Leonenko
Zdorovʹe Rebenka · 2019
doi:10.22141/2224-0551.14.1.2019.157876 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
The article presents modern information about the main pathogenetic mechanisms and clinical manifestations of functional gastrointestinal disorders in infants according to Rome ІV criteria. The requirements for probiotic preparations used in modern medicine are presented. Attention is focused on the main characteristics of the most studied probiotic strain, Lactobacillus rhamnosus GG. The analysis of the results of clinical studies using Lactobacillus rhamnosus GG for the treatment and prevention of functional and organic diseases in children was carried out. The main pharmacological properties and characteristics of Active Flora baby food supplement are presented, which recently appeared on the pharmaceutical market of Ukraine, the main indications for the use of this food supplement are substantiated.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.